From July 1, 2022 to September 30, 2022, the company has repurchased 20,312 shares, representing 0.17% for KRW 1,710.87 million. With this, the company has completed the repurchase of 109,064 shares, representing 0.89% for KRW 9,895.01 million under the buyback announced on February 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
104,500 KRW | +2.15% | -1.42% | -20.17% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.17% | 963M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.